Evidence map›Paper›PMID 37701108›Full record

ArticleTranslational cancer research2023

Novel potential urinary biomarkers for effective diagnosis and prognostic evaluation of high-grade bladder cancer.

Zhi-Guo Zhang, Zhen-Duo Shi, Jia-Jun Dong, Yu-Ang Chen, Ming-Yang Cao, Yun-Tian Li, Wei-Ming Ma, Lin Hao, Kun Pang, Jia-He Zhou and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Zhi-Guo Zhang *Medical College of Soochow University, Suzhou, China.
Zhen-Duo Shi *Department of Urology, Xuzhou Central Hospital, Xuzhou, China.
Jia-Jun Dong *School of Medicine, Jiangsu University, Zhenjiang, China.
Yu-Ang Chen *Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
Ming-Yang CaoXuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
Yun-Tian LiGraduate School of Bengbu Medical College, Bengbu, China.
Wei-Ming MaMedical College of Soochow University, Suzhou, China.
Lin HaoDepartment of Urology, Xuzhou Central Hospital, Xuzhou, China.
Kun PangDepartment of Urology, Xuzhou Central Hospital, Xuzhou, China.
Jia-He ZhouDepartment of Urology, Xuzhou Central Hospital, Xuzhou, China.
Wen-Da ZhangDepartment of Urology, Xuzhou Central Hospital, Xuzhou, China.
Yang DongDepartment of Urology, Xuzhou Central Hospital, Xuzhou, China.
Cong-Hui HanMedical College of Soochow University, Suzhou, China.
Xuzhou Medical College · CNXuzhou Central Hospital · CNJiangsu Normal University · CNBengbu Medical College · CNJiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-grade bladder cancer (HGBC) has a higher malignant potential, recurrence and progression rate compared to low-grade phenotype. Its early symptoms are often vague, making non-invasive diagnosis using urinary biomarkers a promising approach. Methods: The gene expression data from urine samples of patients with HGBC was extracted from the GSE68020 dataset. The clinical information and gene expression data in tumor tissues of HGBC patients were obtained from The Cancer Genome Atlas (TCGA) database. Multivariate Cox analysis was used to predict the optimal risk model. The protein-protein interaction (PPI) analysis was performed via the Search Tool for the Retrieval of Interacting Genes (STRING) database and visualized using Cytoscape. Overall survival (OS) was evaluated in the Gene Expression Profiling Interactive Analysis (GEPIA) online platform. Competing endogenous RNA (ceRNA) network was also visualized using Cytoscape. The expression levels of specific genes were assessed through quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). Moreover, co-expressed genes and potential biological functions related to specific genes were explored based on the Cancer Cell Line Encyclopedia (CCLE) database. Results: A total of 560 differentially expressed genes (DEGs) were identified when comparing the urine sediment samples from HGBC patients with the benign ones. Using these urinary DEGs and the clinical information of HGBC patients, we developed an optimal risk model consisting of eight genes to predict the patient outcome. By integrating the node degree values in the PPI network with the expression changes in both urine and tissue samples, eighteen hub genes were selected out. Among them, DKC1 and SNRPG had the most prominent comprehensive values, and Conclusions: Our study may provide theoretical basis for the development of effective non-invasive detection and treatment strategies, and further research is necessary to explore the clinical applications of these findings.

Indexed as

bioinformaticsdiagnosisHigh-grade bladder cancer (HGBC)prognosisurinary biomarkers

Identifiers

PMID37701108
PMCPMC10493797
OpenAlexW4386170683

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.